These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 20705125)

  • 1. A statistical approach to the development of a transdermal delivery system for ondansetron.
    Obata Y; Ashitaka Y; Kikuchi S; Isowa K; Takayama K
    Int J Pharm; 2010 Oct; 399(1-2):87-93. PubMed ID: 20705125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Feasibility of transdermal delivery of prochlorperazine.
    Obata Y; Otake Y; Takayama K
    Biol Pharm Bull; 2010; 33(8):1454-7. PubMed ID: 20686248
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A combination of nonionic surfactants and iontophoresis to enhance the transdermal drug delivery of ondansetron HCl and diltiazem HCl.
    Silva SM; Hu L; Sousa JJ; Pais AA; Michniak-Kohn BB
    Eur J Pharm Biopharm; 2012 Apr; 80(3):663-73. PubMed ID: 22137964
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of PEG6000 on the in vitro and in vivo transdermal permeation of ondansetron hydrochloride from EVA1802 membranes.
    Krishnaiah YS; Rama B; Raghumurthy V; Ramanamurthy KV; Satyanarayana V
    Pharm Dev Technol; 2009; 14(1):50-61. PubMed ID: 18819031
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and in-vivo evaluation of ondansetron gels for transdermal delivery.
    Patel DR; Joshi A; Patel HH; Stagni G
    Drug Dev Ind Pharm; 2015 Jun; 41(6):1030-6. PubMed ID: 24919508
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug in adhesive type transdermal matrix systems of ondansetron hydrochloride: optimization of permeation pattern using response surface methodology.
    Swain K; Pattnaik S; Sahu SC; Patnaik KK; Mallick S
    J Drug Target; 2010 Feb; 18(2):106-14. PubMed ID: 19712026
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microemulsion as a tool for the transdermal delivery of ondansetron for the treatment of chemotherapy induced nausea and vomiting.
    Al Abood RM; Talegaonkar S; Tariq M; Ahmad FJ
    Colloids Surf B Biointerfaces; 2013 Jan; 101():143-51. PubMed ID: 22796784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrogel-thickened microemulsion for topical administration of drug molecule at an extremely low concentration.
    Chen H; Mou D; Du D; Chang X; Zhu D; Liu J; Xu H; Yang X
    Int J Pharm; 2007 Aug; 341(1-2):78-84. PubMed ID: 17570625
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Formulation study of a patch containing propranolol by design of experiments.
    Cilurzo F; Minghetti P; Gennari CG; Casiraghi A; Selmin F; Montanari L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):17-22. PubMed ID: 23301830
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Penetration-enhancing effect of ethanolic solution of menthol on transdermal permeation of ondansetron hydrochloride across rat epidermis.
    Krishnaiah YS; Kumar MS; Raju V; Lakshmi M; Rama B
    Drug Deliv; 2008 May; 15(4):227-34. PubMed ID: 18446568
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transdermal delivery of naloxone: skin permeation, pharmacokinetic, irritancy and stability studies.
    Panchagnula R; Bokalial R; Sharma P; Khandavilli S
    Int J Pharm; 2005 Apr; 293(1-2):213-23. PubMed ID: 15778059
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on optimizing in vitro transdermal permeation of ondansetron hydrochloride using nerodilol, carvone, and limonene as penetration enhancers.
    Krishnaiah YS; Raju V; Shiva Kumar M; Rama B; Raghumurthy V; Ramana Murthy KV
    Pharm Dev Technol; 2008; 13(3):177-85. PubMed ID: 18484486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ondansetron-loaded chitosan microspheres for nasal antiemetic drug delivery: an alternative approach to oral and parenteral routes.
    Gungor S; Okyar A; Erturk-Toker S; Baktir G; Ozsoy Y
    Drug Dev Ind Pharm; 2010 Jul; 36(7):806-13. PubMed ID: 20136490
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Formulation development, in vitro and in vivo evaluation of membrane controlled transdermal systems of glibenclamide.
    Mutalik S; Udupa N
    J Pharm Pharm Sci; 2005 Jan; 8(1):26-38. PubMed ID: 15946595
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Design and in vivo evaluation of an indapamide transdermal patch.
    Ren C; Fang L; Ling L; Wang Q; Liu S; Zhao L; He Z
    Int J Pharm; 2009 Mar; 370(1-2):129-35. PubMed ID: 19114099
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transdermal Delivery of Ondansetron Hydrochloride via Bilosomal Systems: In Vitro, Ex Vivo, and In Vivo Characterization Studies.
    Ammar HO; Mohamed MI; Tadros MI; Fouly AA
    AAPS PharmSciTech; 2018 Jul; 19(5):2276-2287. PubMed ID: 29845503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Microdialysis sampling coupled to HPLC for transdermal delivery study of ondansetron hydrochloride in rats.
    Ding P; Xu H; Wei G; Zheng J
    Biomed Chromatogr; 2000 May; 14(3):141-3. PubMed ID: 10850615
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Design, development, physicochemical, in vitro and in vivo evaluation of monolithic matrix type transdermal patches containing nitrendipine.
    Mittal A; Sara US; Ali A; Mohammed A
    Pharm Dev Technol; 2009; 14(4):422-34. PubMed ID: 19630699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of formulation pH on transdermal penetration of antiemetics formulated in poloxamer lecithin organogel.
    Woodall R; Arnold JJ; McKay D; Asbill CS
    Int J Pharm Compd; 2013; 17(3):247-53. PubMed ID: 24046940
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.